FMP
Virtus LifeSci Biotech Clinical Trials ETF
BBC
AMEX
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
24.4 USD
0.4064 (1.67%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
CIK
0001559109
ISIN
US26923G3011
CUSIP
26923G301
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Dec 17, 2014
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
BBC Financial Summary
ISIN
US26923G3011
Exchange
AMEX
Beta
0.95
Market Cap
11.06M
52-Week
23.6-31.99
Volume Avg.
2.36k
Price
24.4
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BBC News
It looks like there's no news available.
